3.87
+0.14(+3.75%)
Currency In USD
| Previous Close | 3.73 |
| Open | 3.87 |
| Day High | 3.87 |
| Day Low | 3.87 |
| 52-Week High | 4.01 |
| 52-Week Low | 1.19 |
| Volume | 190,127 |
| Average Volume | 789,055 |
| Market Cap | 106.31M |
| PE | -20.37 |
| EPS | -0.19 |
| Moving Average 50 Days | 3.77 |
| Moving Average 200 Days | 2.57 |
| Change | 0.14 |
If you invested $1000 in iCAD, Inc. (ICAD) 10 years ago, it would be worth $1,060.27 as of August 18, 2025 at a share price of $3.87. Whereas If you bought $1000 worth of iCAD, Inc. (ICAD) shares 5 years ago, it would be worth $364.75 as of August 18, 2025 at a share price of $3.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.
GlobeNewswire Inc.
Jul 08, 2025 12:00 PM GMT
NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, today announced that leading independent proxy advisory firms Instituti
iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
iCAD collaborates with Microsoft to offer radiology providers the option for automated patient reporting on mammography results through PowerScribe integrationNASHUA, N.H., April 29, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the
iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
GlobeNewswire Inc.
Apr 08, 2025 2:19 PM GMT
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today ann